Pivmecillinam (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pivmecillinam" in English language version.

refsWebsite

Global rank English rank

8doi.org

2^nd place

8nih.gov

4^th place

4web.archive.org

1^st place

2medicines.org.uk

3,823^rd place

2,387^th place

1fda.gov

447^th place

338^th place

1archive.today

14^th place

1aspetjournals.org

6,663^rd place

5,792^nd place

archive.today

"Selexid Tablets". electronic Medicines Compendium. 5 June 2008. Archived from the original on 24 December 2012. Retrieved on 31 August 2008.

aspetjournals.org

pharmrev.aspetjournals.org

Brass EP (December 2002). "Pivalate-generating prodrugs and carnitine homeostasis in man". Pharmacol Rev. 54 (4): 589–98. doi:10.1124/pr.54.4.589. PMID 12429869. Archived from the original on 14 December 2019. Retrieved 29 June 2009.

doi.org

Nicolle LE (August 2000). "Pivmecillinam in the treatment of urinary tract infections". J Antimicrob Chemother. 46 (Suppl A): 35–39. doi:10.1093/jac/46.suppl_1.35. PMID 10969050.
Holme E, Greter J, Jacobson CE, et al. (August 1989). "Carnitine deficiency induced by pivampicillin and pivmecillinam therapy". Lancet. 2 (8661): 469–73. doi:10.1016/S0140-6736(89)92086-2. PMID 2570185.
Brass EP (December 2002). "Pivalate-generating prodrugs and carnitine homeostasis in man". Pharmacol Rev. 54 (4): 589–98. doi:10.1124/pr.54.4.589. PMID 12429869. Archived from the original on 14 December 2019. Retrieved 29 June 2009.
Abrahamsson K, Holme E, Jodal U, Lindstedt S, Nordin I (June 1995). "Effect of short-term treatment with pivalic acid containing antibiotics on serum carnitine concentration—a risk irrespective of age". Biochem. Mol. Med. 55 (1): 77–9. doi:10.1006/bmme.1995.1036. PMID 7551831.
Holme E, Jodal U, Linstedt S, Nordin I (September 1992). "Effects of pivalic acid-containing prodrugs on carnitine homeostasis and on response to fasting in children". Scand J Clin Lab Invest. 52 (5): 361–72. doi:10.3109/00365519209088371. PMID 1514015.
Makino Y, Sugiura T, Ito T, Sugiyama N, Koyama N (September 2007). "Carnitine-associated encephalopathy caused by long-term treatment with an antibiotic containing pivalic acid". Pediatrics. 120 (3): e739–41. doi:10.1542/peds.2007-0339. PMID 17724113.
Graninger W (October 2003). "Pivmecillinam—therapy of choice for urinary tract infection". Int J Antimicrob Agents. 22. Suppl 2: 73–8. doi:10.1016/S0924-8579(03)00235-8. PMID 14527775.
Tanphaichitra D, Srimuang S, Chiaprasittigul P, Menday P, Christensen OE (1984). "The combination of pivmecillinam and pivampicillin in the treatment of enteric fever". Infection. 12 (6): 381–3. doi:10.1007/BF01645219. PMID 6569851.

fda.gov

"FDA Approves New Treatment for Uncomplicated Urinary Tract Infections". U.S. Food and Drug Administration (FDA) (Press release). 24 April 2024. Archived from the original on 25 April 2024. Retrieved 25 April 2024. This article incorporates text from this source, which is in the public domain.

medicines.org.uk

"Selexid Summary of Product Characteristics (SmPC)". (emc). 20 March 2024. Archived from the original on 8 November 2023. Retrieved 25 April 2024.

emc.medicines.org.uk

"Selexid Tablets". electronic Medicines Compendium. 5 June 2008. Archived from the original on 24 December 2012. Retrieved on 31 August 2008.

nih.gov

pubmed.ncbi.nlm.nih.gov

Nicolle LE (August 2000). "Pivmecillinam in the treatment of urinary tract infections". J Antimicrob Chemother. 46 (Suppl A): 35–39. doi:10.1093/jac/46.suppl_1.35. PMID 10969050.
Holme E, Greter J, Jacobson CE, et al. (August 1989). "Carnitine deficiency induced by pivampicillin and pivmecillinam therapy". Lancet. 2 (8661): 469–73. doi:10.1016/S0140-6736(89)92086-2. PMID 2570185.
Brass EP (December 2002). "Pivalate-generating prodrugs and carnitine homeostasis in man". Pharmacol Rev. 54 (4): 589–98. doi:10.1124/pr.54.4.589. PMID 12429869. Archived from the original on 14 December 2019. Retrieved 29 June 2009.
Abrahamsson K, Holme E, Jodal U, Lindstedt S, Nordin I (June 1995). "Effect of short-term treatment with pivalic acid containing antibiotics on serum carnitine concentration—a risk irrespective of age". Biochem. Mol. Med. 55 (1): 77–9. doi:10.1006/bmme.1995.1036. PMID 7551831.
Holme E, Jodal U, Linstedt S, Nordin I (September 1992). "Effects of pivalic acid-containing prodrugs on carnitine homeostasis and on response to fasting in children". Scand J Clin Lab Invest. 52 (5): 361–72. doi:10.3109/00365519209088371. PMID 1514015.
Makino Y, Sugiura T, Ito T, Sugiyama N, Koyama N (September 2007). "Carnitine-associated encephalopathy caused by long-term treatment with an antibiotic containing pivalic acid". Pediatrics. 120 (3): e739–41. doi:10.1542/peds.2007-0339. PMID 17724113.
Graninger W (October 2003). "Pivmecillinam—therapy of choice for urinary tract infection". Int J Antimicrob Agents. 22. Suppl 2: 73–8. doi:10.1016/S0924-8579(03)00235-8. PMID 14527775.
Tanphaichitra D, Srimuang S, Chiaprasittigul P, Menday P, Christensen OE (1984). "The combination of pivmecillinam and pivampicillin in the treatment of enteric fever". Infection. 12 (6): 381–3. doi:10.1007/BF01645219. PMID 6569851.

web.archive.org

"Selexid Summary of Product Characteristics (SmPC)". (emc). 20 March 2024. Archived from the original on 8 November 2023. Retrieved 25 April 2024.
fda.gov
"FDA Approves New Treatment for Uncomplicated Urinary Tract Infections". U.S. Food and Drug Administration (FDA) (Press release). 24 April 2024. Archived from the original on 25 April 2024. Retrieved 25 April 2024. This article incorporates text from this source, which is in the public domain.
Brass EP (December 2002). "Pivalate-generating prodrugs and carnitine homeostasis in man". Pharmacol Rev. 54 (4): 589–98. doi:10.1124/pr.54.4.589. PMID 12429869. Archived from the original on 14 December 2019. Retrieved 29 June 2009.